🔎 Trials Near Me

Akèy › Kansè pwostat › Kalifòni › San Diego

Etid klinik pou Kansè pwostat nan San Diego, CA

31 etid pou Kansè pwostat ap chèche patisipan nan sit nan ak bò kote San Diego (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Ap rekriteFaz 1
  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06465069

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Ap rekriteFaz 1/2
  • University of San Diego Moores Cancer Center, La Jolla · 11 mi lwen
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04585750

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Ap rekriteFaz 3
  • UC San Diego Medical Center - Hillcrest, San Diego
  • UC San Diego Moores Cancer Center, La Jolla · 11 mi lwen
Laj 18 ak plis · Gason · Mizajou Oct 2, 2026 · NCT06931340

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Ap rekriteFaz 3
  • UC San Diego Medical Center - Hillcrest, San Diego
  • UC San Diego Moores Cancer Center, La Jolla · 11 mi lwen
Laj 18 ak plis · Gason · Mizajou Oct 2, 2026 · NCT07200830

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Ap rekriteFaz 2
  • UC San Diego Medical Center - Hillcrest, San Diego
  • UC San Diego Moores Cancer Center, La Jolla · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06632977

Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix

Ap rekriteEtid obsèvasyon
  • Om Research, San Diego
Laj 40 a 75 · Gason · Mizajou Sep 28, 2026 · NCT07543757

Precision-Based Genomics in Prostate Cancer

Ap rekriteEtid obsèvasyon
  • University of California San Diego, La Jolla · 11 mi lwen
Laj 18 a 120 · Gason · Mizajou Sep 28, 2026 · NCT04706663

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

Ap rekriteFaz 1
  • University of California San Diego, Moores Cancer Center, La Jolla · 11 mi lwen
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT06801236

DESTINY-PANTUMOUR04

Ap rekriteEtid obsèvasyon
  • Research Site, San Diego
Laj 18 a 130 · Tout sèks · Mizajou Sep 25, 2026 · NCT07124000

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

Ap rekriteFaz 3
  • Research Site, San Diego
  • Research Site, La Jolla · 11 mi lwen
  • Research Site, La Jolla · 11 mi lwen
Laj 18 ak plis · Gason · Mizajou Sep 18, 2026 · NCT06952803

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Ap rekriteFaz 3
  • Moores Cancer Center ( Site 0010), La Jolla · 11 mi lwen
Laj 18 ak plis · Gason · Mizajou Sep 17, 2026 · NCT06925737

First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

Ap rekriteFaz 1/2
  • GSK Investigational Site, La Jolla · 11 mi lwen
Laj 18 ak plis · Gason · Mizajou Sep 16, 2026 · NCT07332455

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

Ap rekriteFaz 2
  • Sharp HealthCare - Sharp Memorial Hospital, San Diego
Laj 18 ak plis · Gason · Mizajou Sep 3, 2026 · NCT07005154

Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer

Ap rekriteFaz 1
  • UC San Diego Moores Cancer Center, La Jolla · 11 mi lwen
Laj 18 ak plis · Gason · Mizajou Sep 3, 2026 · NCT07545811

A Study of Tarlatamab for People With Prostate Cancer

Ap rekriteFaz 2
  • UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only), San Diego
Laj 18 ak plis · Gason · Mizajou Aug 31, 2026 · NCT07111507

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

Ap rekriteFaz 2
  • UCSD Moores Cancer Center, La Jolla · 11 mi lwen
Laj 18 ak plis · Gason · Mizajou Aug 21, 2026 · NCT06844383

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Ap rekriteFaz 3
  • UC San Diego Medical Center - Hillcrest, San Diego
  • UC San Diego Moores Cancer Center, La Jolla · 11 mi lwen
Laj 18 ak plis · Gason · Mizajou Aug 19, 2026 · NCT04423211

Strategic Endocrine Therapy and Targeted Radiotherapy for Prostate Cancer

Ap rekriteFaz 2
  • University of California San Diego, La Jolla · 11 mi lwen
Laj 18 ak plis · Gason · Mizajou Aug 4, 2026 · NCT07364071

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1
  • Investigative Site #101, La Jolla · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 23, 2026 · NCT06545942

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Ap rekriteFaz 3
  • Kaiser Permanente-San Diego Zion, San Diego
Laj 18 ak plis · Gason · Mizajou Jul 14, 2026 · NCT06592924

TERPS Trial for de Novo Oligometastic Prostate Cancer

Ap rekriteFaz 2
  • UC San Diego Moores Cancer Center, La Jolla · 11 mi lwen
Laj 18 ak plis · Gason · Mizajou Jun 3, 2026 · NCT05223803

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

Ap rekriteEtid obsèvasyon
  • University of California San Diego, San Diego
Laj 21 ak plis · Gason · Mizajou May 22, 2026 · NCT03151629

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

Ap rekriteFaz 1
  • Research Site, San Diego
Laj 18 ak plis · Gason · Mizajou May 12, 2026 · NCT06879041

Image-guided, Tumor-focused Radiotherapy Treatment in Intermediate and High-risk Prostate Cancer

Ap rekriteFaz 2
  • University of California, San Diego, La Jolla · 11 mi lwen
Laj 18 ak plis · Gason · Mizajou Feb 17, 2026 · NCT06990542

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, La Jolla · 11 mi lwen
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Ap rekriteFaz 3
  • UC San Diego Moores Cancer Center, La Jolla · 11 mi lwen
Laj 18 ak plis · Gason · Mizajou Sep 11, 2025 · NCT03678025

Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)

Ap rekrite
  • University of California, San Diego, La Jolla · 11 mi lwen
Tout laj · Gason · Mizajou Jul 17, 2025 · NCT05882253

Prostate Assessment with Restriction Spectrum Imaging (RSI) MRI

Ap rekriteEtid obsèvasyon
  • UCSD Moores Cancer Center, La Jolla · 11 mi lwen
Laj 18 ak plis · Gason · Mizajou Feb 6, 2025 · NCT04992728

ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer

Ap rekriteEtid obsèvasyon
  • University of California San Diego, San Diego
Laj 18 ak plis · Gason · Mizajou Nov 6, 2024 · NCT06579417

Focal Therapy for Localized Prostate Cancer

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • University of California, San Diego, La Jolla · 11 mi lwen
Laj 18 ak plis · Gason · Mizajou Feb 26, 2024 · NCT06270043

Etid Kansè pwostat nan lòt vil

Lòt etid nan San Diego

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.